Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | +3.90% | +0.63% | +2.56% |
05-13 | Compass Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-06 | Top Premarket Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.56% | 220M | |
+8.29% | 114B | |
+10.21% | 104B | |
+1.11% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- CMPX Stock
- News Compass Therapeutics, Inc.
- Roth Capital Initiates Compass Therapeutics at Buy Rating With $15 Price Target